Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 16
2 Introduction 19
2.1 What Is This Report
About? 19
3 Definitions of Markets Covered in the Report 20
3.1
Cardiovascular Devices 20
3.2 Cardiac Rhythm Management 20
3.2.1
Pacemakers 20
3.2.2 Implantable Cardioverter Defibrillator (ICD) 20
3.2.3 Cardiovascular Pacing and ICD Leads 21
3.2.4 Cardiac
Resynchronization Therapy 21
3.3 Cardiovascular monitoring and diagnostic
devices 21
3.3.1 ECG Monitoring Equipment 21
3.3.2 ECG Stress Testing
Systems 21
3.3.3 Holter Monitoring Systems 21
3.3.4 Event Monitoring
Systems 21
3.4 Cardiovascular prosthetic device 22
3.4.1 Prosthetic
heart valves 22
3.4.2 Cardiac Valve Repair 22
3.4.3 Cardiac assist
devices 22
3.5 Cardiovascular Surgery 23
3.5.1 Beating Heart Systems
23
3.5.2 Perfusion Systems 23
3.5.3 Cardiac Ablation Devices 23
3.5.4 Cardiopulmonary Bypass Equipment 23
3.5.5 Perfusion Disposables
23
3.6 Electrophysiology 24
3.6.1 Electrophysiology diagnostic
catheter 24
3.6.2 Electrophysiology ablation catheter 24
3.6.3
Electrophysiology lab systems 24
3.7 Interventional cardiology 24
3.7.1 Coronary Stents 24
3.7.2 Cardiac Catheters 24
3.7.3 Percutaneous
Transluminal Coronary Balloon (PTCA) Balloon Catheters 25
3.7.4 Coronary
Guidewire 25
3.7.5 Arteriotomy Closure Devices 25
3.8 Peripheral
vascular devices 25
3.8.1 Peripheral Vascular Stents 26
3.8.2 Inferior
Vena Cava Filter 26
3.8.3 PTA Balloon 26
3.8.4 Aortic Stent Graft
26
3.8.5 Embolic Protection Device 26
3.8.6 Synthetic Surgical Grafts
26
3.8.7 Peripheral Guidewire 26
4 Healthcare Sector Review 27
4.1
Healthcare Sector Review 27
4.2 Healthcare Expenditure 27
4.3
Healthcare Infrastructure 29
4.3.1 Healthcare Personnel Data 30
4.3.2
Healthcare Facilities Data 31
4.4 Healthcare Policy 32
5 Regulation
System 33
5.1 Medical Equipment Approval Process 33
5.1.1
Classification 34
5.1.2 Conformity Assessment Process 42
5.1.3
Registration Fee 46
5.1.4 Registration Period 46
5.2 Post Market
Surveillance (PMS) 47
6 Pricing and Reimbursement 48
6.1 Pricing and
Reimbursement Policies 48
7 Distribution Structure 49
7.1 France
Medical Equipment Distribution Structure 49
8 Cardiovascular Devices In
France 50
8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($
mn), 2000-2015 50
8.2 Cardiovascular Devices, France, Overall Revenue ($
mn), 2000-2015 51
8.3 Cardiovascular Devices, France, Category Volume
(Units), 2000-2015 57
8.4 Cardiovascular Devices, France, Company Share
(2007-2008) 59
9 Cardiac Rhythm Management In France 60
9.1 Cardiac
Rhythm Management Overall Revenue (2000-2015) 60
9.1.1 Cardiac
Resynchronisation Therapy Revenue (2000-2015) 62
9.1.2 Implantable
Cardioverter Defibrillator Revenue (2000-2015) 64
9.1.3 Pacemaker Revenue
(2000-2015) 66
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
68
9.2.1 Cardiac Resynchronisation Therapy Volume (2000-2015) 70
9.2.2
Implantable Cardioverter Defibrillator Volume (2000-2015) 72
9.2.3
Pacemaker Volume (2000-2015) 74
9.3 Cardiac Rhythm Management Average
Price (2000-2015) 76
9.4 Cardiac Rhythm Management Distribution Share
(2007-2008) 77
9.5 Cardiac Rhythm Management, France, Company Share
(2007-2008) 78
10 Cardiovascular Monitoring and Diagnostic Devices In
France 79
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall
Revenue (2000-2015) 79
10.2 Cardiovascular Monitoring and Diagnostic
Devices Overall Volume (2000-2015) 83
10.3 Cardiovascular Monitoring and
Diagnostic Devices Average Price (2000-2015) 85
10.4 Cardiovascular
Monitoring and Diagnostic Devices Distribution Share (2007-2008) 86
10.5
Cardiovascular Monitoring and Diagnostic Devices, France, Company Share
(2007-2008) 87
11 Cardiovascular Prosthetic Devices In France 88
11.1
Cardiovascular Prosthetic Devices Overall Revenue (2000-2015) 88
11.1.1
Cardiac Assist Devices Revenue (2000-2015) 90
11.1.2 Prosthetic Heart
Valve Revenue (2000-2015) 92
11.2 Cardiovascular Prosthetic Devices
Overall Volume (2000-2015) 94
11.2.1 Cardiac Assist Devices Volume
(2000-2015) 96
11.2.2 Prosthetic Heart Valve Volume (2000-2015) 98
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015) 100
11.4
Cardiovascular Prosthetic Devices Distribution Share (2007-2008) 101
11.5
Cardiovascular Prosthetic Devices, France, Company Share (2007-2008) 102
12 Cardiovascular Surgery In France 103
12.1 Cardiovascular Surgery
Overall Revenue (2000-2015) 103
12.1.1 Perfusion Disposables Revenue
(2000-2015) 105
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
107
12.2.1 Perfusion Disposables Volume (2000-2015) 108
12.3
Cardiovascular Surgery Average Price (2000-2015) 110
12.4 Cardiovascular
Surgery Distribution Share (2007-2008) 111
12.5 Cardiovascular Surgery,
France, Company Share (2007-2008) 112
13 Electrophysiology In France
113
13.1 Electrophysiology Overall Revenue (2000-2015) 113
13.2
Electrophysiology Overall Volume (2000-2015) 115
13.3 Electrophysiology
Average Price (2000-2015) 116
13.4 Electrophysiology Distribution Share
(2007-2008) 117
13.5 Electrophysiology, France, Company Share (2007-2008)
118
14 Interventional Cardiology In France 119
14.1 Interventional
Cardiology Overall Revenue (2000-2015) 119
14.1.1 Cardiac Catheter Revenue
(2000-2015) 123
14.1.2 Coronary Stent Revnue (2000-2015) 125
14.1.3
PTCA Balloon Revenue (2000-2015) 127
14.2 Interventional Cardiology
Overall Volume (2000-2015) 129
14.2.1 Cardiac Catheter Volume (2000-2015)
133
14.2.2 Coronary Stent Volume (2000-2015) 135
14.2.3 PTCA Balloon
Volume (2000-2015) 137
14.3 Interventional Cardiology Average Price
(2000-2015) 139
14.4 Interventional Cardiology Distribution Share
(2007-2008) 141
14.5 Interventional Cardiology, France, Company Share
(2007-2008) 142
15 Peripheral Vascular Devices In France 143
15.1
Peripheral Vascular Devices Overall Revenue (2000-2015) 143
15.2
Peripheral Vascular Devices Overall Volume (2000-2015) 147
15.3 Peripheral
Vascular Devices Average Price (2000-2015) 149
15.4 Peripheral Vascular
Devices Distribution Share (2007-2008) 150
15.5 Peripheral Vascular
Devices, France, Company Share (2007-2008) 151
16 Overview of Key
Companies in France Cardiovascular Devices Market 152
16.1 Welch Allyn
Inc. 152
16.1.1 Company Overview 152
16.2 Thoratec Corporation 153
16.2.1 Company Overview 153
16.2.2 Value Chain Analysis 154
16.2.3
Thoratec Corporation Pipeline Products 156
16.3 Terumo Corporation 157
16.3.1 Company Overview 157
16.3.2 Value Chain Analysis 157
16.3.3
Terumo Corporation Pipeline Products 159
16.4 St. Jude Medical, Inc.
162
16.4.1 Company Overview 162
16.4.2 Value Chain Analysis 163
16.4.3 St. Jude Medical Inc. Pipeline Products 165
16.5 Sorin S.p.A.
169
16.5.1 Company Overview 169
16.5.2 Value Chain Analysis 170
16.5.3 Sorin Group Pipeline Products 173
16.6 Philips Healthcare 175
16.6.1 Company Overview 175
16.6.2 Value Chain Analysis 175
16.7 OSI
Systems, Inc. 178
16.7.1 Company Overview 178
16.7.2 Value Chain
Analysis 178
16.8 Nihon Kohden Corporation 180
16.8.1 Company Overview
180
16.8.2 Value Chain Analysis 181
16.9 Medtronic, Inc. 183
16.9.1 Company Overview 183
16.9.2 Value Chain Analysis 184
16.9.3
Medtronic, Inc. Pipeline Products 186
16.10 MAQUET GmbH & Co. KG 195
16.10.1 Company Overview 195
16.11 Invatec S.r.l. 196
16.11.1 Company
Overview 196
16.11.2 Invatec S.r.l. Pipeline Products 196
16.12
HEXACATH 200
16.12.1 Company Overview 200
16.13 GE Healthcare 200
16.13.1 Company Overview 200
16.14 Fukuda Denshi Co., Ltd. 200
16.14.1
Company Overview 200
16.15 ev3 Inc. 201
16.15.1 Company Overview
201
16.15.2 Value Chain Analysis 202
16.15.3 ev3 Inc. Pipeline
Products 204
16.16 Edwards Lifesciences Corporation 206
16.16.1
Company Overview 206
16.16.2 Value Chain Analysis 206
16.16.3 Edwards
Lifesciences Corporation Pipeline Products 208
16.17 Datascope Corporation
211
16.17.1 Company Overview 211
16.17.2 Value Chain Analysis 211
16.18 CryoCath Technologies Inc. 214
16.18.1 Company Overview 214
16.18.2 CryoCath Technologies Inc. Pipeline Products 214
16.19 Cordis
Corporation 216
16.19.1 Company Overview 216
16.19.2 Cordis
Corporation Pipeline Products 216
16.20 Cardiac Science Corporation
218
16.20.1 Company Overview 218
16.20.2 Value Chain Analysis 219
16.21 C.R. Bard, Inc. 221
16.21.1 Company Overview 221
16.21.2 Value
Chain Analysis 221
16.21.3 C.R. Bard, Inc. Pipeline Products 223
16.22
Boston Scientific Corporation 225
16.22.1 Company Overview 225
16.22.2
Value Chain Analysis 226
16.22.3 Boston Scientific Corporation Pipeline
Products 229
16.23 BIOTRONIK GmbH & Co. KG 234
16.23.1 Company
Overview 234
16.23.2 BIOTRONIK GmbH & Co. KG Pipeline Products 234
16.24 Biosense Webster, Inc. 236
16.24.1 Company Overview 236
16.25
AtriCure, Inc. 237
16.25.1 Company Overview 237
16.25.2 AtriCure, Inc.
Pipeline Products 237
16.26 Arrow International, Inc. 239
16.26.1
Company Overview 239
16.26.2 Value Chain Analysis 240
16.26.3 Arrow
International, Inc. Pipeline Products 242
16.27 ABIOMED, Inc. 243
16.27.1 Company Overview 243
16.27.2 Value Chain Analysis 243
16.27.3
ABIOMED, Inc. Pipeline Products 245
16.28 Abbott Laboratories 247
16.28.1 Company Overview 247
16.28.2 Value Chain Analysis 248
16.29
Stentys, S.A.S. 251
16.29.1 Company Overview 251
16.29.2 Stentys,
S.A.S. Pipeline Products 251
16.30 Arterial Remodeling Technologies
253
16.30.1 Company Overview 253
16.30.2 Arterial Remodeling
Technologies Pipeline Products 253
16.31 ALN implants chirurgicaux 254
16.31.1 Company Overview 254
16.32 ARTHESYS 254
16.32.1 Company
Overview 254
17 Recent Developments 255
17.1 Government and Public
Interest 255
17.1.1 May 14, 2009: EHRA And HRS Release Expert Consensus
Statement On The Catheter Ablation of VT 255
17.1.2 Mar 20, 2009: New
Coalition Launches ' Stent 4 Life' Campaign, To Increase The Use Of Primary PCI
In Acute Coronary Patients 256
18 Appendix 257
18.1 Global Markets
Direct Research Methodology 257
18.2 Coverage 258
18.3 Secondary
Research 258
18.4 Primary Research 259
18.5 Models 259
18.6
Forecasts 260
18.7 Expert Panel Validation 260
18.8 Currency
Conversion 261
18.9 Contact Us 262
18.10 Disclaimer 262
1.1 List of Tables
Table 1: Number of Doctors by Specialty in France,
2003-2007 30
Table 2: Number of Hospital Wards by Specialty in France,
2003-2007 31
Table 3: Cardiovascular Devices Cross Country
Comparison, Revenue ($ mn), 2000-2015 50
Table 4: Cardiovascular
Devices, France, Overall Revenue ($ mn), 2000-2015 51
Table 5:
Cardiovascular Devices, France, Cross-Category Analysis, 2000-2015 52
Table 6: Cardiovascular Devices, France, Overall Revenue ($ mn),
Historic, 2000-2008 54
Table 7: Cardiovascular Devices, France,
Overall Revenue ($ mn), Forecast, 2008-2015 56
Table 8:
Cardiovascular Devices, France, Category Volume (Units), 2000-2015 57
Table 9: Cardiovascular Devices, France, Category Volume (Units),
Historic, 2000-2008 57
Table 10: Cardiovascular Devices, France,
Category Volume (Units), Forecast, 2008-2015 58
Table 11:
Cardiovascular Devices, France, Company Share by Revenue ($ mn), 2007-2008
59
Table 12: Cardiac Rhythm Management, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 60
Table 13: Cardiac Rhythm Management,
France, Revenue ($ mn) by Segment, Forecast, 2008-2015 61
Table 14:
Cardiac Resynchronisation Therapy, France, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 62
Table 15: Cardiac Resynchronisation Therapy,
France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 63
Table 16:
Implantable Cardioverter Defibrillator, France, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 64
Table 17: Implantable
Cardioverter Defibrillator, France, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 65
Table 18: Pacemaker, France, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 66
Table 19: Pacemaker, France,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 67
Table 20:
Cardiac Rhythm Management, France, Volume (Units) by Segment, Historic,
2000-2008 68
Table 21: Cardiac Rhythm Management, France, Volume
(Units) by Segment, Forecast, 2008-2015 69
Table 22: Cardiac
Resynchronisation Therapy, France, Volume (Units) by Sub-Segment, Historic,
2000-2008 70
Table 23: Cardiac Resynchronisation Therapy, France,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 71
Table 24:
Implantable Cardioverter Defibrillator, France, Volume (Units) by Sub-Segment,
Historic, 2000-2008 72
Table 25: Implantable Cardioverter
Defibrillator, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015
73
Table 26: Pacemaker, France, Volume (Units) by Sub-Segment,
Historic, 2000-2008 74
Table 27: Pacemaker, France, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 75
Table 28: Cardiac Rhythm
Management, France, Average Price ($), Historic, 2000-2008 76
Table 29:
Cardiac Rhythm Management, France, Average Price ($), Forecast, 2008-2015
76
Table 30: Cardiac Rhythm Management, France, Distribution Share by
Revenue ($mn), 2007-2008 77
Table 31: Cardiac Rhythm Management,
France, Company Share by Revenue ($ mn), 2007-2008 78
Table 32:
Cardiovascular Monitoring and Diagnostic Devices, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 80
Table 33: Cardiovascular Monitoring
and Diagnostic Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015
82
Table 34: Cardiovascular Monitoring and Diagnostic Devices,
France, Volume (Units) by Segment, Historic, 2000-2008 83
Table 35:
Cardiovascular Monitoring and Diagnostic Devices, France, Volume (Units) by
Segment, Forecast, 2008-2015 84
Table 36: Cardiovascular Monitoring
and Diagnostic Devices, France, Average Price ($), Historic, 2000-2008 85
Table 37: Cardiovascular Monitoring and Diagnostic Devices, France,
Average Price ($), Forecast, 2008-2015 85
Table 38: Cardiovascular
Monitoring and Diagnostic Devices, France, Distribution Share by Revenue
($mn), 2007-2008 86
Table 39: Cardiovascular Monitoring and
Diagnostic Devices, France, Company Share by Revenue ($ mn), 2007-2008 87
Table 40: Cardiovascular Prosthetic Devices, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 88
Table 41: Cardiovascular Prosthetic
Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 89
Table
42: Cardiac Assist Devices, France, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 90
Table 43: Cardiac Assist Devices, France,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 91
Table 44:
Prosthetic Heart Valve, France, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 92
Table 45: Prosthetic Heart Valve, France, Revenue ($ mn)
by Sub-Segment, Forecast, 2008-2015 93
Table 46: Cardiovascular
Prosthetic Devices, France, Volume (Units) by Segment, Historic, 2000-2008
94
Table 47: Cardiovascular Prosthetic Devices, France, Volume
(Units) by Segment, Forecast, 2008-2015 95
Table 48: Cardiac Assist
Devices, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 96
Table 49: Cardiac Assist Devices, France, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 97
Table 50: Prosthetic Heart Valve, France,
Volume (Units) by Sub-Segment, Historic, 2000-2008 98
Table 51:
Prosthetic Heart Valve, France, Volume (Units) by Sub-Segment, Forecast,
2008-2015 99
Table 52: Cardiovascular Prosthetic Devices, France,
Average Price ($), Historic, 2000-2008 100
Table 53: Cardiovascular
Prosthetic Devices, France, Average Price ($), Forecast, 2008-2015 100
Table 54: Cardiovascular Prosthetic Devices, France, Distribution Share
by Revenue ($mn), 2007-2008 101
Table 55: Cardiovascular Prosthetic
Devices, France, Company Share by Revenue ($ mn), 2007-2008 102
Table 56:
Cardiovascular Surgery, France, Revenue ($ mn) by Segment, Historic,
2000-2008 103
Table 57: Cardiovascular Surgery, France, Revenue ($
mn) by Segment, Forecast, 2008-2015 104
Table 58: Perfusion
Disposables, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
105
Table 59: Perfusion Disposables, France, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 106
Table 60: Cardiovascular
Surgery, France, Volume (Units) by Segment, Historic, 2000-2008 107
Table
61: Cardiovascular Surgery, France, Volume (Units) by Segment, Forecast,
2008-2015 107
Table 62: Perfusion Disposables, France, Volume (Units)
by Sub-Segment, Historic, 2000-2008 108
Table 63: Perfusion
Disposables, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015
109
Table 64: Cardiovascular Surgery, France, Average Price ($),
Historic, 2000-2008 110
Table 65: Cardiovascular Surgery, France,
Average Price ($), Forecast, 2008-2015 110
Table 66: Cardiovascular
Surgery, France, Distribution Share by Revenue ($mn), 2007-2008 111
Table
67: Cardiovascular Surgery, France, Company Share by Revenue ($ mn),
2007-2008 112
Table 68: Electrophysiology, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 113
Table 69: Electrophysiology, France,
Revenue ($ mn) by Segment, Forecast, 2008-2015 114
Table 70:
Electrophysiology, France, Volume (Units) by Segment, Historic, 2000-2008
115
Table 71: Electrophysiology, France, Volume (Units) by Segment,
Forecast, 2008-2015 115
Table 72: Electrophysiology, France, Average
Price ($), Historic, 2000-2008 116
Table 73: Electrophysiology,
France, Average Price ($), Forecast, 2008-2015 116
Table 74:
Electrophysiology, France, Distribution Share by Revenue ($mn), 2007-2008
117
Table 75: Electrophysiology, France, Company Share by Revenue ($
mn), 2007-2008 118
Table 76: Interventional Cardiology, France,
Revenue ($ mn) by Segment, Historic, 2000-2008 120
Table 77:
Interventional Cardiology, France, Revenue ($ mn) by Segment, Forecast,
2008-2015 122
Table 78: Cardiac Catheter, France, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 123
Table 79: Cardiac Catheter,
France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 124
Table 80:
Coronary Stent, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
125
Table 81: Coronary Stent, France, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 126
Table 82: PTCA Balloon, France, Revenue ($
mn) by Sub-Segment, Historic, 2000-2008 127
Table 83: PTCA Balloon,
France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 128
Table 84:
Interventional Cardiology, France, Volume (Units) by Segment, Historic,
2000-2008 130
Table 85: Interventional Cardiology, France, Volume
(Units) by Segment, Forecast, 2008-2015 132
Table 86: Cardiac
Catheter, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 133
Table 87: Cardiac Catheter, France, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 134
Table 88: Coronary Stent, France, Volume
(Units) by Sub-Segment, Historic, 2000-2008 135
Table 89: Coronary
Stent, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 136
Table 90: PTCA Balloon, France, Volume (Units) by Sub-Segment, Historic,
2000-2008 137
Table 91: PTCA Balloon, France, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 138
Table 92: Interventional
Cardiology, France, Average Price ($), Historic, 2000-2008 139
Table 93:
Interventional Cardiology, France, Average Price ($), Forecast, 2008-2015
140
Table 94: Interventional Cardiology, France, Distribution Share
by Revenue ($mn), 2007-2008 141
Table 95: Interventional Cardiology,
France, Company Share by Revenue ($ mn), 2007-2008 142
Table 96:
Peripheral Vascular Devices, France, Revenue ($ mn) by Segment, Historic,
2000-2008 144
Table 97: Peripheral Vascular Devices, France, Revenue
($ mn) by Segment, Forecast, 2008-2015 146
Table 98: Peripheral
Vascular Devices, France, Volume (Units) by Segment, Historic, 2000-2008
147
Table 99: Peripheral Vascular Devices, France, Volume (Units) by
Segment, Forecast, 2008-2015 148
Table 100: Peripheral Vascular
Devices, France, Average Price ($), Historic, 2000-2008 149
Table 101:
Peripheral Vascular Devices, France, Average Price ($), Forecast, 2008-2015
149
Table 102: Peripheral Vascular Devices, France, Distribution
Share by Revenue ($mn), 2007-2008 150
Table 103: Peripheral Vascular
Devices, France, Company Share by Revenue ($ mn), 2007-2008 151
Table 104:
Thoratec Corporation Pipeline Products by Equipment Type 156
Table
105: Thoratec Corporation Pipeline Products By Development Stage 156
Table 106: Thoratec Corporation Pipeline Products By Therapy Area 156
Table 107: Thoratec Corporation Pipeline Products By Clinical Trials
156
Table 108: Thoratec Corporation Pipeline Products By News Summary
156
Table 109: Terumo Corporation Pipeline Products by Equipment Type
159
Table 110: Terumo Corporation Pipeline Products By Development
Stage 159
Table 111: Terumo Corporation Pipeline Products By Therapy
Area 160
Table 112: Terumo Corporation Pipeline Products By Clinical
Trials 160
Table 113: Terumo Corporation Pipeline Products By News
Summary 161
Table 114: St. Jude Medical Inc. Pipeline Products by
Equipment Type 165
Table 115: St. Jude Medical Inc. Pipeline Products
By Development Stage 166
Table 116: St. Jude Medical Inc. Pipeline
Products By Therapy Area 167
Table 117: St. Jude Medical Inc.
Pipeline Products By Clinical Trials 168
Table 118: St. Jude Medical
Inc. Pipeline Products By News Summary 168
Table 119: Sorin Group
Pipeline Products by Equipment Type 173
Table 120: Sorin Group
Pipeline Products By Development Stage 173
Table 121: Sorin Group
Pipeline Products By Therapy Area 174
Table 122: Sorin Group Pipeline
Products By Clinical Trials 174
Table 123: Sorin Group Pipeline
Products By News Summary 174
Table 124: Medtronic, Inc. Pipeline
Products by Equipment Type 186
Table 125: Medtronic, Inc. Pipeline
Products By Development Stage 188
Table 126: Medtronic, Inc. Pipeline
Products By Therapy Area 190
Table 127: Medtronic, Inc. Pipeline
Products By Clinical Trials 192
Table 128: Medtronic, Inc. Pipeline
Products By News Summary 193
Table 129: Invatec S.r.l. Pipeline
Products by Equipment Type 196
Table 130: Invatec S.r.l. Pipeline
Products By Development Stage 197
Table 131: Invatec S.r.l. Pipeline
Products By Therapy Area 198
Table 132: Invatec S.r.l. Pipeline
Products By Clinical Trials 199
Table 133: Invatec S.r.l. Pipeline
Products By News Summary 199
Table 134: ev3 Inc. Pipeline Products by
Equipment Type 204
Table 135: ev3 Inc. Pipeline Products By
Development Stage 204
Table 136: ev3 Inc. Pipeline Products By
Therapy Area 205
Table 137: ev3 Inc. Pipeline Products By Clinical
Trials 205
Table 138: ev3 Inc. Pipeline Products By News Summary
205
Table 139: Edwards Lifesciences Corporation Pipeline Products by
Equipment Type 208
Table 140: Edwards Lifesciences Corporation
Pipeline Products By Development Stage 209
Table 141: Edwards
Lifesciences Corporation Pipeline Products By Therapy Area 209
Table 142:
Edwards Lifesciences Corporation Pipeline Products By Clinical Trials
210
Table 143: Edwards Lifesciences Corporation Pipeline Products By
News Summary 210
Table 144: CryoCath Technologies Inc. Pipeline
Products by Equipment Type 214
Table 145: CryoCath Technologies Inc.
Pipeline Products By Development Stage 214
Table 146: CryoCath
Technologies Inc. Pipeline Products By Therapy Area 214
Table 147:
CryoCath Technologies Inc. Pipeline Products By Clinical Trials 215
Table
148: CryoCath Technologies Inc. Pipeline Products By News Summary 215
Table 149: Cordis Corporation Pipeline Products by Equipment Type 216
Table 150: Cordis Corporation Pipeline Products By Development Stage
216
Table 151: Cordis Corporation Pipeline Products By Therapy Area
217
Table 152: Cordis Corporation Pipeline Products By Clinical
Trials 217
Table 153: Cordis Corporation Pipeline Products By News
Summary 217
Table 154: C.R. Bard, Inc. Pipeline Products by Equipment
Type 223
Table 155: C.R. Bard, Inc. Pipeline Products By Development
Stage 224
Table 156: C.R. Bard, Inc. Pipeline Products By Therapy
Area 224
Table 157: C.R. Bard, Inc. Pipeline Products By Clinical
Trials 224
Table 158: Boston Scientific Corporation Pipeline Products
by Equipment Type 229
Table 159: Boston Scientific Corporation
Pipeline Products By Development Stage 230
Table 160: Boston
Scientific Corporation Pipeline Products By Therapy Area 231
Table 161:
Boston Scientific Corporation Pipeline Products By Clinical Trials 232
Table 162: Boston Scientific Corporation Pipeline Products By News
Summary 233
Table 163: BIOTRONIK GmbH & Co. KG Pipeline Products by
Equipment Type 234
Table 164: BIOTRONIK GmbH & Co. KG Pipeline
Products By Development Stage 234
Table 165: BIOTRONIK GmbH & Co. KG
Pipeline Products By Therapy Area 235
Table 166: BIOTRONIK GmbH & Co.
KG Pipeline Products By Clinical Trials 235
Table 167: BIOTRONIK GmbH
& Co. KG Pipeline Products By News Summary 235
Table 168: AtriCure,
Inc. Pipeline Products by Equipment Type 237
Table 169: AtriCure,
Inc. Pipeline Products By Development Stage 237
Table 170: AtriCure,
Inc. Pipeline Products By Therapy Area 238
Table 171: AtriCure, Inc.
Pipeline Products By Clinical Trials 238
Table 172: AtriCure, Inc.
Pipeline Products By News Summary 238
Table 173: Arrow International,
Inc. Pipeline Products by Equipment Type 242
Table 174: Arrow
International, Inc. Pipeline Products By Development Stage 242
Table 175:
Arrow International, Inc. Pipeline Products By Therapy Area 242
Table
176: Arrow International, Inc. Pipeline Products By Clinical Trials
242
Table 177: ABIOMED, Inc. Pipeline Products by Equipment Type
245
Table 178: ABIOMED, Inc. Pipeline Products By Development Stage
245
Table 179: ABIOMED, Inc. Pipeline Products By Therapy Area
245
Table 180: ABIOMED, Inc. Pipeline Products By Clinical Trials
246
Table 181: ABIOMED, Inc. Pipeline Products By News Summary
246
Table 182: Stentys, S.A.S. Pipeline Products by Equipment Type
251
Table 183: Stentys, S.A.S. Pipeline Products By Development Stage
251
Table 184: Stentys, S.A.S. Pipeline Products By Therapy Area
251
Table 185: Stentys, S.A.S. Pipeline Products By Clinical Trials
252
Table 186: Stentys, S.A.S. Pipeline Products By News Summary
252
Table 187: Arterial Remodeling Technologies Pipeline Products by
Equipment Type 253
Table 188: Arterial Remodeling Technologies
Pipeline Products By Development Stage 253
Table 189: Arterial
Remodeling Technologies Pipeline Products By Therapy Area 253
Table 190:
USD to Local Currency, Average Exchange Rate 2008 261
1.2
List of Figures
Figure 1: Total Healthcare Expenditure in France, 2000 -
2006 28
Figure 2: Flowchart for Classification of Non-invasive Devices in
France, 2007 35
Figure 3: Flowchart for Classification of Invasive Devices
in France, 2007 36
Figure 4: Flowchart for Classification of Invasive
Devices in France, 2007 37
Figure 5: Flowchart for Classification of
Invasive Devices in France, 2007 38
Figure 6: Flowchart for Classification
of Invasive Devices in France, 2007 39
Figure 7: Flowchart for
Classification of Active Devices in France, 2007 40
Figure 8: Flowchart
for Classification of Active Devices in France, 2007 41
Figure 9:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in France, 2007 42
Figure 10: Conformity Assessment of
Class-I Medical Devices in France, 2007 43
Figure 11: Conformity
Assessment of Class-IIa Medical Devices in France, 2007 44
Figure 12:
Conformity Assessment of Class-IIb Medical Devices in France, 2007 45
Figure 13: Conformity Assessment of Class-III Medical Devices in France, 2007
46
Figure 14: Medical Equipment Distribution Structure in France, 2007
49
Figure 15: Cardiovascular Devices Cross Country Comparison,
Revenue ($ mn), 2000-2015 50
Figure 16: Cardiovascular Devices,
France, Overall Revenue ($ mn), 2000-2015 51
Figure 17: Cardiovascular
Devices, France, Cross-Category Analysis, 2000-2015 52
Figure 18:
Cardiovascular Devices, France, Overall Revenue ($ mn), Historic, 2000-2008
53
Figure 19: Cardiovascular Devices, France, Overall Revenue ($ mn),
Forecast, 2008-2015 55
Figure 20: Cardiovascular Devices, France,
Company Share (%), 2008 59
Figure 21: Cardiac Rhythm Management,
France, Revenue ($ mn) by Segment, Historic, 2000-2008 60
Figure 22:
Cardiac Rhythm Management, France, Revenue ($ mn) by Segment, Forecast,
2008-2015 61
Figure 23: Cardiac Resynchronisation Therapy, France,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 62
Figure 24:
Cardiac Resynchronisation Therapy, France, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 63
Figure 25: Implantable Cardioverter
Defibrillator, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
64
Figure 26: Implantable Cardioverter Defibrillator, France, Revenue
($ mn) by Sub-Segment, Forecast, 2008-2015 65
Figure 27: Pacemaker,
France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 66
Figure 28:
Pacemaker, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
67
Figure 29: Cardiac Rhythm Management, France, Volume (Units) by
Segment, Historic, 2000-2008 68
Figure 30: Cardiac Rhythm Management,
France, Volume (Units) by Segment, Forecast, 2008-2015 69
Figure 31:
Cardiac Resynchronisation Therapy, France, Volume (Units) by Sub-Segment,
Historic, 2000-2008 70
Figure 32: Cardiac Resynchronisation Therapy,
France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 71
Figure 33:
Implantable Cardioverter Defibrillator, France, Volume (Units) by
Sub-Segment, Historic, 2000-2008 72
Figure 34: Implantable
Cardioverter Defibrillator, France, Volume (Units) by Sub-Segment, Forecast,
2008-2015 73
Figure 35: Pacemaker, France, Volume (Units) by
Sub-Segment, Historic, 2000-2008 74
Figure 36: Pacemaker, France,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 75
Figure 37:
Cardiac Rhythm Management, France, Company Share (%), 2008 78
Figure 38:
Cardiovascular Monitoring and Diagnostic Devices, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 79
Figure 39: Cardiovascular Monitoring
and Diagnostic Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015
81
Figure 40: Cardiovascular Monitoring and Diagnostic Devices,
France, Volume (Units) by Segment, Historic, 2000-2008 83
Figure 41:
Cardiovascular Monitoring and Diagnostic Devices, France, Volume (Units) by
Segment, Forecast, 2008-2015 84
Figure 42: Cardiovascular Monitoring
and Diagnostic Devices, France, Company Share (%), 2008 87
Figure 43:
Cardiovascular Prosthetic Devices, France, Revenue ($ mn) by Segment,
Historic, 2000-2008 88
Figure 44: Cardiovascular Prosthetic Devices,
France, Revenue ($ mn) by Segment, Forecast, 2008-2015 89
Figure 45:
Cardiac Assist Devices, France, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 90
Figure 46: Cardiac Assist Devices, France, Revenue ($
mn) by Sub-Segment, Forecast, 2008-2015 91
Figure 47: Prosthetic
Heart Valve, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 92
Figure 48: Prosthetic Heart Valve, France, Revenue ($ mn) by Sub-Segment,
Forecast, 2008-2015 93
Figure 49: Cardiovascular Prosthetic Devices,
France, Volume (Units) by Segment, Historic, 2000-2008 94
Figure 50:
Cardiovascular Prosthetic Devices, France, Volume (Units) by Segment,
Forecast, 2008-2015 95
Figure 51: Cardiac Assist Devices, France,
Volume (Units) by Sub-Segment, Historic, 2000-2008 96
Figure 52:
Cardiac Assist Devices, France, Volume (Units) by Sub-Segment, Forecast,
2008-2015 97
Figure 53: Prosthetic Heart Valve, France, Volume
(Units) by Sub-Segment, Historic, 2000-2008 98
Figure 54: Prosthetic
Heart Valve, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 99
Figure 55: Cardiovascular Prosthetic Devices, France, Company Share (%),
2008 102
Figure 56: Cardiovascular Surgery, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 103
Figure 57: Cardiovascular Surgery,
France, Revenue ($ mn) by Segment, Forecast, 2008-2015 104
Figure 58:
Perfusion Disposables, France, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 105
Figure 59: Perfusion Disposables, France, Revenue ($
mn) by Sub-Segment, Forecast, 2008-2015 106
Figure 60: Perfusion
Disposables, Fra
|
Related Report
|
View Cart
